首页> Leukemia research> Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia.

Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia.

导出 LinkOut

翻译打印收藏纠错

第一作者： Regina,García-Delgado

第一单位： Hospital Universitario Virgen de la Victoria, Málaga, Spain. Electronic address: reginagarciadel@yahoo.es.

作者： Regina,García-Delgado ^[1] ; Dunia,de Miguel ^[2] ; Alicia,Bailén ^[3] ; José Ramón,González ^[4] ; Joan,Bargay ^[5] ; José F,Falantes ^[6] ; Rafael,Andreu ^[7] ; Fernando,Ramos ^[8] ; Mar,Tormo ^[9] ; Salut,Brunet ^[10] ; Antonio,Figueredo ^[11] ; Javier,Casaño ^[12] ; Angeles,Medina ^[13] ; Llorenç,Badiella ^[14] ; Antonio Fernández,Jurado ^[15] ; Guillermo,Sanz ^[16]

作者单位： Hospital Universitario Virgen de la Victoria, Málaga, Spain. Electronic address: reginagarciadel@yahoo.es. ^[1] Hospital Universitario de Guadalajara, Madrid, Spain. ^[2] Hospital Carlos Haya, Málaga, Spain. ^[3] Hospital Clínico Universitario, Salamanca, Spain. ^[4] Hospital Son Llatzer, Palma de Mallorca, Spain. ^[5] Hospital Universitario Virgen del Rocío, IBIS, Seville, Spain. ^[6] Hospital Doctor Peset, Valencia, Spain. ^[7] Hospital General de León, León, Spain. ^[8] Hospital Clínico Universitario de Valencia, Valencia, Spain. ^[9] Hospital Santa Creu i Sant Pau, Barcelona, Spain. ^[10] Hospital Virgen Macarena, Seville, Spain. ^[11] Hospital Reina Sofia, Córdoba, Spain. ^[12] Hospital Costa del Sol, Marbella, Spain. ^[13] Servei d'Estadística Aplicada, Universitat Autònoma de Barcelona, Barcelona, Spain. ^[14] Hospital Juan Ramón Jiménez, Huelva, Spain, on behalf of the Asociación Andaluza de Hematología y Hemoterapia, Spain. ^[15] Hospital Universitario La Fe, Valencia, Spain. ^[16]

关键词 Acute myeloid leukemia Azacitidine Dosing schedules Myelodysplastic syndromes Overall survival Safety